61755-014-01 : NDC 2026 Code

61755-014-01 : Pozelimab ( Veopoz )

Additionally :

You can get information about “61755-014-01” NDC code in 61755-014-01 in HTML format

HTML | 61755-014-01 in TXT (Plain Text) format

TXT | 61755-014-01 in PDF (Portable Document Format)

PDF | 61755-014-01 in XML format

XML formats.

NDC Code : 61755-014-01 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "61755-014-01",
    "PackageDescription": "1 VIAL, SINGLE-DOSE in 1 CARTON (61755-014-01)  / 2 mL in 1 VIAL, SINGLE-DOSE (61755-014-00) ",
    "NDC11Code": "61755-0014-01",
    "ProductNDC": "61755-014",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Veopoz",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Pozelimab",
    "DosageFormName": "INJECTION, SOLUTION",
    "RouteName": "INTRAVENOUS; SUBCUTANEOUS",
    "StartMarketingDate": "20230818",
    "EndMarketingDate": null,
    "MarketingCategoryName": "BLA",
    "ApplicationNumber": "BLA761339",
    "LabelerName": "Regeneron Pharmaceuticals, Inc.",
    "SubstanceName": "POZELIMAB",
    "StrengthNumber": "200",
    "StrengthUnit": "mg/mL",
    "Pharm_Classes": "Complement Inhibitor [EPC], Complement Inhibitors [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-12-16",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20230818",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}